Pages that link to "Q30408026"
Jump to navigation
Jump to search
The following pages link to Hypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells (Q30408026):
Displaying 15 items.
- From sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculation (Q26827148) (← links)
- Orphan nuclear receptor Nur77 Inhibits Oxidized LDL-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells (Q34762092) (← links)
- The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer (Q34771536) (← links)
- Bile acids regulate nuclear receptor (Nur77) expression and intracellular location to control proliferation and apoptosis (Q35108902) (← links)
- NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation (Q38286252) (← links)
- Nuclear receptor 4A (NR4A) family - orphans no more (Q39013661) (← links)
- Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment (Q41913079) (← links)
- Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma (Q42274085) (← links)
- Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent (Q48182968) (← links)
- Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma (Q49317150) (← links)
- Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin (Q51066152) (← links)
- Characteristics of Nur77 and its ligands as potential anticancer compounds (Review) (Q57068599) (← links)
- MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression (Q91783137) (← links)
- Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas (Q92124140) (← links)
- Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFβ-induced invasion of embryonal rhabdomyosarcoma cells (Q99241256) (← links)